Premature ejaculation: a clinical update.

Area of Science:

• Urology
• Sexual Medicine
• Psychiatry

Background:

• Premature ejaculation (PE) is a prevalent male sexual dysfunction characterized by lack of ejaculatory control, causing significant distress.
• It is the most common sexual complaint among men, impacting interpersonal relationships.
• Primary PE has a physiological basis, while secondary PE is often linked to other conditions like erectile dysfunction.

Purpose of the Study:

• To outline the therapeutic aims for premature ejaculation (PE).
• To review effective treatment strategies for primary and secondary PE.
• To emphasize the importance of partner involvement in PE therapy.

Main Methods:

• Review of established therapeutic approaches for PE.
• Discussion of pharmacological interventions including selective serotonin reuptuptake inhibitors (SSRIs) and topical anesthetics.
• Emphasis on addressing underlying causes for secondary PE.

Main Results:

• Selective serotonin reuptake inhibitors (SSRIs), administered daily or on-demand, are highly effective for primary PE.
• Topical anesthetics also demonstrate efficacy in managing PE.
• Treating the underlying condition, such as erectile dysfunction, is key for secondary PE.

Conclusions:

• Effective management of PE is achievable through targeted therapies.
• Regaining ejaculatory control and ensuring partner satisfaction are primary therapeutic goals.
• A comprehensive approach involving the individual and partner is crucial for successful PE treatment.